Please do not leave this page until complete. This can take a few moments.
IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that exceeded Wall Street estimates and raised its outlook for all of 2023.
The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water testing posted $2.55 in earnings per diluted share, an increase of 12% as reported and 18% on a comparable basis. Earnings per share exceeded the $2.34 consensus estimate of analysts polled by Zacks Investment Research.
IDEXX attributed the increase to solid gross margin gains and benefits from a $16 million customer contract resolution payment. Results included 6 cents per share in tax benefits from share-based compensation and an 11 cents per share negative impact from currency changes.
First-quarter revenue was $900.2 million, exceeding the Zacks consensus estimate by 1.45%. IDEXX has topped consensus revenue estimates three times over the last three quarters, and exceeded consensus EPS estimates four times.
"Strong execution by IDEXX commercial and operational teams drove excellent growth results and financial performance in the first quarter," said Jay Mazelsky, CEO and president of IDEXX. "Commercial engagement and IDEXX innovations are supporting our customers as they work to address growing demand for pet healthcare. IDEXX's ongoing focus on addressing the needs of veterinary clinics is aligned with developing the long-term global growth opportunity for companion animal diagnostics.”
IDEXX shares were trading 5.21% lower at $464.08 in the late morning, for a market capitalization of around $38.5 billion.
Looking ahead to the full year, IDEXX updated its 2022 revenue growth outlook to a range of 7.5% to 10% as reported and organically. The change reflects consistent goals for organic revenue growth at the high end and an increase of 0.5% at the low end.
The overall reported revenue range was also increased by $10 million, or around 0.5%, for updated foreign exchange effects.
The company’s updated EPS outlook range of $9.33 to $9.75 maintains a consistent high end estimate and raises the low end by 6 cents.
IDEXX employs nearly 11,000 people and offers solutions and products to customers in more than 175 countries.
The Giving Guide helps nonprofits have the opportunity to showcase and differentiate their organizations so that businesses better understand how they can contribute to a nonprofit’s mission and work.
Learn MoreWork for ME is a workforce development tool to help Maine’s employers target Maine’s emerging workforce. Work for ME highlights each industry, its impact on Maine’s economy, the jobs available to entry-level workers, the training and education needed to get a career started.
Learn MoreFew people are adequately prepared for all the tasks involved in planning and providing care for aging family members. SeniorSmart provides an essential road map for navigating the process. This resource guide explores the myriad of care options and offers essential information on topics ranging from self-care to legal and financial preparedness.
Learn moreThe Giving Guide helps nonprofits have the opportunity to showcase and differentiate their organizations so that businesses better understand how they can contribute to a nonprofit’s mission and work.
Work for ME is a workforce development tool to help Maine’s employers target Maine’s emerging workforce. Work for ME highlights each industry, its impact on Maine’s economy, the jobs available to entry-level workers, the training and education needed to get a career started.
Few people are adequately prepared for all the tasks involved in planning and providing care for aging family members. SeniorSmart provides an essential road map for navigating the process. This resource guide explores the myriad of care options and offers essential information on topics ranging from self-care to legal and financial preparedness.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments